申请人:A. H. Robins Company, Incorporated
公开号:US05273972A1
公开(公告)日:1993-12-28
This invention provides novel 2-substituted-3-quinuclidinyl arylcarboxamides and arylthiocarboxamides and corresponding arylcarboxylates which have utility as therapeutic agents which exhibit gastric prokinetic, antiemetic, anxiolytic and 5-HT (serotonin) antagonist effects in warm blooded animals. Illustrative of an invention compound is 5-chloro-2-methoxy-4-(methylamino)-N-[2-(1-piperidinylmethyl)-1-azabicyclo [2.2.2]oct-3-yl]benzamide: ##STR1## or a pharmaceutically acceptable salt thereof.
这项发明提供了新型的2-取代-3-喹诺啉基芳基羧酰胺和芳硫酰胺,以及对应的芳基羧酸酯,这些化合物作为治疗剂具有胃动力学、抗恶心、抗焦虑和对温血动物产生5-HT(血清素)拮抗效应的功效。该发明化合物的示例是5-氯-2-甲氧基-4-(甲氨基)-N-[2-(1-哌啶甲基)-1-氮杂双环[2.2.2]辛-3-基]苯甲酰胺或其药学上可接受的盐。